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ABSTRACT
Major beta thalassemia (MBT) is a hereditary disease which synthesies defects in beta chains of haemoglobin, it is
causes red blood cell destruction and the symptoms of anemia. Red blood cell destruction, frequent blood transfu -
sion and low adherence to routine use of iron chelator lead to iron accumulation in the heart, liver and endocrine
organs. Accumulation of iron in the myocard can lead acute myocardial infarction. One of cardiac markers that
had been used for the diagnosis of myocardial infarction was cardiac troponin I (cTnI). The aim of this research is
find the correlation between serum ferritin levels and cTnI in MBT children. A descriptive analytic research was
conducted using a cross sectional design. The subjects were divided into 2 groups, the MBT group and the control
group. In both groups, the serum ferritin and cTnI levels ere evaluated. Data were analyzed using t-test and Pear -
son correlation test. Eleven children in the MBT group and 11 children in the control group were involved in this
study. In the MBT group, the mean of serum ferritin and cTnI levels were 4292.5 µg/L and 0.20 ng/mL respec-
tively. The mean of serum ferritin levels in the MBT group were higher than in the control and statistically signifi -
cant (p= 0.0004). The mean of serum ferritin levels in the MBT group were higher than in the control and statisti-
cally significant (p= 0.0004). The mean of serum cTnI in the MBT group were higher than in the control, but sta -
tistically not significant (p= 0.82). In the MBT group, there was a weak corellation between serum ferritin and
cTnI levels (r= 0.34).
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Major beta thalassemia (MBT) is a hereditary dis-
ease  which  synthesies  defects  in  beta  chains  of
haemoglobin. MBT causes red blood cell destruction,
leads to anemic symptoms and need for regular blood
transfusions  [1,  2,  3].  Haemolysis  and regular  blood
transfusions can lead to iron overload in the liver, en-
docrine organs and myocardium [1, 3] Iron overload
can  be  evaluated  easily  and  verified  by  measuring
serum ferritin levels [1, 4, 5]. High serum ferritin levels
increase the risk of myocardial infarction in adults.6,7
Myocardial  infark  can  be  diagnosed  by  the  cardial
biomarker cardiac troponin I (cTnI) [8]. In Indonesia,
the correlation between serum ferritin level and cTnI in
MBT children has never been studied. 
Study design
A descriptive analytic research was conducted using
a cross sectional design, on May 2015, at the Pediatric
Departement  and Clinical  Pathology Departement  of
Syaiful Anwar General Hospital (SAGH) Malang, In-
donesia,  and  approved  by  the  ethics  committee  of
SAGH. The subjects were divided into 2 groups, the
MBT group and the control group. 
The patients
Inclusion criteria of MBT subjects were children 1
-18 years old, diagnosed as MBT by haemoglobin elec-
trophoresis, needing regular blood transfusion and ap-
proved by their parents after informed consent. Inclu-
sion criteria for the control groups were children 1 -18
years  old,  not  diagnosed as  MBT, never had regular
blood transfusion and approved by their parents after
informed consent. Respondents were excluded if they
had autoimmune haemolytics anemia, iron deficiency
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anemia, aplastic anemia, severe infections, malignancy,
severe  malnutrition and congenital  or  acquired heart
disease. 
Assays
In both groups were perform laboratory examina-
tion of peripheral blood to checks the serum ferritin
and cTnI levels. Serum ferritin levels were measured by
immunoturbidimetry  assays  using  FERR3:ACN165,
Roche/Hitachi  cobas  c  system analyzer  (US).  Serum
cTnI  level  were  measured  by  sandwich  im-
munochroma-tography  using  AIM TROPONIN I  Q
Rapid test (Indonesia). 
Statistical analyses
The differences in serum ferritin and cTnI levels be-
tween the MBT and control groups were analyzed by a
t-test. The correlation between serum ferritin and cTnI
levels in the MBT group were analyzed by a Pearson
correlation  test.  Confidence  interval  95%  (α=  0.05)
Data were analyzed using SPSS for Windows 16.0. 
The subjects of this study were 22 children, 11 chil-
dren in the MBT group and 11 children in the control
group. The mean of age of the MBT and the control
groups were 123 months and 69 months respectively.
In the MBT group, 8 of 11 were male and 7 of 11 were
in good nutritional status. In the control group, 7 of 11
were male and 7 of 11 were had a good nutritional sta-
tus. In the MBT group, palor was in all patients, Coo-
ley’s face in 9 of 11, spleen enlargement in 10 of 11
and short stature in 9 of 11. Whereas in the control
group,  there was  no palor,  Cooley’s  face,  spleen en-
largement  or short  stature.  All  subjects  in  the  MBT
group were got  Packed Red Cell  (PRC) transfusions
regularly every 1 - 2 months as well as iron chelator
medication  and  no  one  of  control  group  got  PRC
transfusions or iron chelator (Table 1). 
Complete blood count result showed the average of
haemoglobin  level  before  transfusion  in  the  MBT
group  was  6.5  g/dL  that  lower  than  in  the  control
group whose haemoglobin level was 12.5 g/dL. The av-
erage of erythrocytes in the MBT group and control
groups were 2.9  × 106  /µL and 4.86 × 106  /µL respec-
tively. The average of leukocyte in the MBT group and
control groups were 9.02  × 103 /µL and 7.6  × 103  /µL
respectively. The average of thrombocyte  in  the  MBT
group and control  groups were 247.8  × 103  /µL and
294.9 × 103 /µL respectively (Table 1).
Table 1. Subjects characteristics
Characteristics MBT Control
Respondents (n) 11 11
Average age (months) 123 69
Gender (Male / Female) 8 / 3 7 / 4
Nutritional status   
-   Well nourished 7/11 7/11
-   Under nourished 4/11 3/11
-   Obese 0 1/11
Clinical signs   
-   Pale 11/11 0/11
-   Cooley’s face 9/11 0/11
-   Short stature 9/11 0/11
-   Splenomegali 10/11 0/11
Regular PRC transfusion 11/11 0/11
Iron chelator medication 11/11 0/11
(mean ± SD) (mean ±  SD)
Haemoglobin (g/dL) 6.5 ± 1.04 12.5 ± 1.03
Erythrocites (106 /μL) 2.9 ± 0.5 4.86 ± 0.4
Leukocytes (103 /μL) 9.02 ± 7.2 7.6 ± 4.01
Thrombocytes (103 /μL) 247.8 ± 221.9 294.9 ± 84.99
The mean of serum ferritin level in the MBTgroups
was  4292.5  µg/L  higher  than  it  was  in  the  control
groups with only 136.2  µg/L. Statistics analyses   by t
test showed there was a significant difference in serum
feritin levels between the MBT and control groups (p
value = 0.0004). The mean of cTnI in the MBT group
was  0.22  ng/mL,  higher  than  it  was  in  the  control
group with only 0.20 ng/mL. Statistics analyses by t
test indicated difference of cTnI level between the MBT
and control groups was not significant (p value = 0.82)
(Table 2). In the MBT group, the result of Pearson cor-
relation test showed there was a weak correlation be-
tween serum ferritin and cTnI levels (r value = 0.34)
(Figure 1). 
The age average of the children in the MBT group
was  10  years  3  months.  MBT  is  usually  diagnosed
when the children are under 2 years old [9]. In this re-
Table 2. Serum ferritin and cTnI levels
Parameter MBT (mean ± SD)
Control 
(mean ± SD) p value
Ferritin (µg/L)  4292.5 ± 2660  136.2 ± 168.8  0.0004
cTnI (ng/mL) 0.22 ± 0.24 0.20 ± 0.23 0.82
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Figure 1. Correlation between serum ferritin and cTnI level in
MBT children
search, respondents in the MBT group had got regular
PRC transfusion every 1-2 months for many years. The
older MBT patiens are more susceptible to complica-
tions, such as heart, liver and endocrines disturbance
[10].   
Eight out of 11 children in the MBT group were
male, the male to female ratio being 8:3. Another study
in thalassemic children in Surabaya had a male to fe-
male ratio of 44 : 17 [11] but in Jakarta this ratio was
37 : 36 [12]. Male and female proportions in MBT pa-
tients  are  influenced  by  autosomal  ressessive  inheri-
tance and not sex chromosomal linked [2, 9].
Seven children out of 11 in the MBT group had
good  nutritional  status.  It  was  shown they  had had
proper  medical  and nutritional  care.  All  the patients
(11/11) in the MBT group were pale, caused by ery-
throcytes damage and ineffective erythrocytes synthesis
due to globin chain defect [13,14]. Furthermore, almost
all patients in the MBT group had splenomegalli but
there were no one in the control group. The spleen was
the main organ for erythrocyte degradation [2].
A majority of children (9 / 11) in the MBT group
had short stature, whereas, all children in the control
group had normal stature. In MBT patients, the short
stature  was  caused  by  growth  hormon  disturbance,
chronic hypoxia due to chronic anemia and cardiovas-
cular disturbance [10]. A majority of the children (9 /
11)  in  the  MBT  group  suffered  from  Cooley’s  face
caused by erythropoitic expansion in the bone marrow
leading to the skull and face bone deformities [13].
Complete blood count results showed the average
of haemoglobin levels before transfusion in the MBT
group  were  lower  than  those  in  the  control  group.
Haemoglobin levels in thalassemic children were less
than 7 g/dL when diagnosed at the first time [9]. Ane-
mia in the MBT children was caused by erythrocyte
damage  and  ineffective  erythrocyte  synthesis  due  to
globin chain defect [13, 14]. The laboratory tests for es-
tablishing the diagnoses of MBT were erythrocyte in-
dex,  peripheral  blood  smear  and  haemoglobin  elec-
trophoresis [15]. The average leukocyte and thrombo-
cyte  counts  in  both  groups  were  within  the  normal
limits.
The average serum ferritin level in the MBT group
was 4292.5 µg/L, which was not only higer than that in
the control group but also higher than normal limits
(20 – 200  µg/L). Statistics analyses by t test showed
significant differences in serum ferritin levels between
the MBT and control  groups  (p  value  =  0.0004).  A
study in China also found high serum ferritin levels in
MBT patients, 2754 µg/L [16]. Another study on Egyp-
tian children with MBT also found high serum ferritin
levels, 4510  µg/L [17]. Serum ferritin levels of  more
than 1000 µg/L. was indicate iron overload [18]. 
Iron overload in MBT patients  is  caused by ery-
throcyte  damage,  frequent  PRC transfusions  and  in-
creased iron absorbtion [19]. Continual iron overload
will lead to iron deposition in the liver, heart and en-
docrine organs [1, 3]. Non transferin-bound forms of
iron (NTBI) in the cytoplasmic can induce the conver-
tion of Fe2+ to Fe3+ and lead increase free radicals such
as reactive oxygen species [20]. Free radicals will in-
duce  lipid  peroxidation  in  the  cell  organels  such  as
lysosom,  mitochondria  and  cytoplasmic  membranes.
Lipid  peroxidation can disturb the  cell  function and
cause cell necrosis including miocytes in the myocar-
dial layer [20]. Iron chelator medication will not only
reduced the iron deposition and labile iron but also re-
duced free radicals [4].
The average cTnI levels in the MBT group was 0.22
ng/mL which  was  higher  than  those  in  the  control
group at 0.20 ng/mL, but the differences in cTnI levels
between both groups were not statistically significant
(p= 0.82). Based on equipment standard were used in
this study, the serum cTnI levels were normal if less
than 0.8 ng/mL. This result  showed the serum cTnI
levels in both groups were within normal limits. The
normal serum cTnI levels indicated there was no my-
ocardial injury in either groups. The myocardial injury
leads to myocyte damage and induces the leakage of
cTnI into the systemic circulation. Increasing cTnI lev-
els can be detected although in the intial myocardial
injuries even if echocardiography can not detect it [19].
The  correlation  between  the  serum  ferritin  and
cTnI levels in the MBT group was weak positive corre-
lation (r value=0.34). It was mean increasing of serum
feritin level will increase the serum cTnI level. Serum
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cTnI  level  higher  than  normal  had  100% sensitivity
and 96.3% specificity for diagnosing the myocardial in-
farction [21]. cTnI serum levels was higher than nor-
mal indicate mycordial injury [22]. Higher than nor-
mal cTnI levels increase the mortality rates [21].
Antioxydant enzymes such as catalase, superoxide
dismutase and glutation give cell protection from ox-
idative stress [23, 24]. The effects of free radicals and
oxidative stress on MBT patient can be neutralized by
antioxidant additives such as Vitamin E and N-asetyl-
cystein [25]. 
The results of this study showed that serum cTnI
levels in the MBT group was within normal limits al-
though serum ferritin level was high. This might been
cused  by regular  iron chelator  medication;  the  good
nutritional status of the majority of MBT children and
the consumption of sufficient antioxidant such as Vita-
min A, Vitamin C and Vitamin E.
The average serum ferritin levels in the MBT group
were higher than those in the control group and the
statistical difference was significant. The average serum
cTnI levels in the MBT group were higher than in the
control group, but this was not statistically significant.
There was a weak positive correlation between serum
ferritin and cTnI levels in the MBT group.
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